FFCP PHASE1:Mm9::chr17:33774766..33774775,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=378460|HGNC=|MCL_coexpression_id=3|UniProt=Q6BCL1|association_with_transcript=-225bp_to_ENSMUST00000052079,NM_001002842,uc008bzb.2_5end|description=CAGE_peak_4_at_Pram1_5end|id=chr17:33774766..33774775,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,3.30e-15,9|ontology_enrichment_disease=DOID:0060100!6.22e-15!3;DOID:4045!6.22e-15!3;DOID:0050686!1.07e-07!6|ontology_enrichment_disease_v019_2=DOID:0060100,8.97e-44,3;DOID:4045,8.97e-44,3;DOID:0050686,2.23e-22,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.30e-15,9;UBERON:0002036,3.30e-15,9;UBERON:0002385,3.30e-15,9;UBERON:0000486,3.30e-15,9;UBERON:0007503,3.30e-15,9;UBERON:0001015,3.30e-15,9;UBERON:0002329,3.30e-15,9;UBERON:0003082,3.30e-15,9;UBERON:0003059,3.30e-15,9;UBERON:0007282,3.30e-15,9;UBERON:0004290,3.30e-15,9;UBERON:0009618,3.30e-15,9;UBERON:0000383,9.08e-14,10;UBERON:0007524,1.37e-12,11;UBERON:0003077,1.37e-12,11;UBERON:0007285,1.37e-12,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.0671387065287,12.5013655123808,12.0410461113974,34.1174263057988,25.9557284284209,9.22469670759192,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202860121388503,0.482354319504834,0.25462585178142,0,0,0.274561413188081,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.136694227721025,0,0,0.139951452323658,0,0,0,0,0,0,0,0.134864346384821,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0936415074698824,0.0640251524048693,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0985044823755635,0,0,0,0,0,0,0,0.220591419119515,0|short_description=p4@Pram1}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=378460 | |||
|HGNC= | |||
|MCL_coexpression_id=3 | |||
|TSSclassifier=NA | |||
|UniProt=Q6BCL1 | |||
|association_with_transcript=-225bp_to_ENSMUST00000052079,NM_001002842,uc008bzb.2_5end | |||
|cluster_id=chr17:33774766..33774775,+ | |||
|description=CAGE_peak_4_at_Pram1_5end | |||
|id=chr17:33774766..33774775,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,3.30e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!6.22e-15!3;DOID:4045!6.22e-15!3;DOID:0050686!1.07e-07!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,8.97e-44,3;DOID:4045,8.97e-44,3;DOID:0050686,2.23e-22,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.30e-15,9;UBERON:0002036,3.30e-15,9;UBERON:0002385,3.30e-15,9;UBERON:0000486,3.30e-15,9;UBERON:0007503,3.30e-15,9;UBERON:0001015,3.30e-15,9;UBERON:0002329,3.30e-15,9;UBERON:0003082,3.30e-15,9;UBERON:0003059,3.30e-15,9;UBERON:0007282,3.30e-15,9;UBERON:0004290,3.30e-15,9;UBERON:0009618,3.30e-15,9;UBERON:0000383,9.08e-14,10;UBERON:0007524,1.37e-12,11;UBERON:0003077,1.37e-12,11;UBERON:0007285,1.37e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.0671387065287,12.5013655123808,12.0410461113974,34.1174263057988,25.9557284284209,9.22469670759192,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202860121388503,0.482354319504834,0.25462585178142,0,0,0.274561413188081,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.136694227721025,0,0,0.139951452323658,0,0,0,0,0,0,0,0.134864346384821,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0936415074698824,0.0640251524048693,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0985044823755635,0,0,0,0,0,0,0,0.220591419119515,0 | |||
|short_description=p4@Pram1 | |||
}} |
Latest revision as of 06:50, 26 September 2015
Short description: | p4@Pram1 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_4_at_Pram1_5end |
Coexpression cluster: | MCL_coexpression_mm9:3 |
Association with transcript: | -225bp_to_ENSMUST00000052079, NM_001002842, uc008bzb.2_5end |
EntrezGene: | Pram1 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 3.30e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 3.30e-15 | 9 |
striated muscle tissue | 3.30e-15 | 9 |
muscle tissue | 3.30e-15 | 9 |
multilaminar epithelium | 3.30e-15 | 9 |
epithelial vesicle | 3.30e-15 | 9 |
musculature | 3.30e-15 | 9 |
somite | 3.30e-15 | 9 |
myotome | 3.30e-15 | 9 |
presomitic mesoderm | 3.30e-15 | 9 |
presumptive segmental plate | 3.30e-15 | 9 |
dermomyotome | 3.30e-15 | 9 |
trunk paraxial mesoderm | 3.30e-15 | 9 |
musculature of body | 9.08e-14 | 10 |
dense mesenchyme tissue | 1.37e-12 | 11 |
paraxial mesoderm | 1.37e-12 | 11 |
presumptive paraxial mesoderm | 1.37e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 8.97e-44 | 3 |
muscle cancer | 8.97e-44 | 3 |
organ system cancer | 2.23e-22 | 6 |